# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
The Company is initiating clinical studies to further validate Intelligent Fingerprinting Drug Screening SystemINBS anticipates...
Intelligent Bio Solutions Inc. (NASDAQ:INBS) ("INBS" or the "Company"), a medical technology company delivering...
Intelligent Bio Solutions Inc. (NASDAQ:INBS) ("INBS" or the "Company"), a medical technology company delivering...
Intelligent Bio Solutions (NASDAQ:INBS) reported quarterly losses of $(0.36) per share. The company reported $843.884 thousand...
Intelligent Bio Solutions Inc. (NASDAQ:INBS) ("INBS" or the "Company"), a medical technology company delivering...